Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19

Clinical trial NCT05137795 · WITHDRAWN

Trial details

NCT number: NCT05137795
Sponsor: APR Applied Pharma Research s.a.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV 2 COVID ARDS ALI Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Dyspnea

Start date: 2021-12-15
Primary completion: 2022-06-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.